Mary E. Rothstein

HGF and c-Met Participate in Paracrine Tumorigenic Pathways in Head and Neck Squamous Cell Cancer

Lynn M. Knowles, Laura P. Stabile, Ann Marie Egloff et al. · Clinical Cancer Research · 2009 · 227 citations

Estrogen receptor beta (ERβ) subtype-specific ligands increase transcription, p44/p42 mitogen activated protein kinase (MAPK) activation and growth in human non-small cell lung cancer cells

Pamela A. Hershberger, Laura P. Stabile, Beatriz Kanterewicz et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2009 · 105 citations · Full text

Tumor Biology, Estrogen Receptor Beta, Medicine +12

Cross-Talk between Estrogen Receptor and Epidermal Growth Factor Receptor in Head and Neck Squamous Cell Carcinoma

Ann Marie Egloff, Mary E. Rothstein, Raja R. Seethala et al. · Clinical Cancer Research · 2009 · 87 citations · Full text

Combining the Multitargeted Tyrosine Kinase Inhibitor Vandetanib with the Antiestrogen Fulvestrant Enhances Its Antitumor Effect in Non-small Cell Lung Cancer

Jill M. Siegfried, Christopher T. Gubish, Mary E. Rothstein et al. · Journal of Thoracic Oncology · 2012 · 67 citations · Full text

Antiestrogen Fulvestrant, Medicine, Pharmacology +7

Prevention of tobacco carcinogen-induced lung cancer in female mice using antiestrogens

Laura P. Stabile, Mary E. Rothstein, Diana E. Cunningham et al. · Carcinogenesis · 2012 · 52 citations · Full text

Chemoprevention Strategy, Pharmacotherapy, Female Mice +21